We explored their therapeutic efficacy and found that intravenously delivered EPCs can home to the ischemic brain and improve long-term stroke outcomes in focal cerebral ischemia, and CXCL12-mediated signaling was involved in EPC-mediated neuroprotection [197]. Here, CXCL12 is linked to stroke disorder.